JPMORGAN CHASE & CO - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$20,000
+181718.2%
159,009
+43.6%
0.00%
Q4 2022$11
-99.9%
110,709
+1.8%
0.00%
Q3 2022$17,000
-81.5%
108,796
+4.4%
0.00%
Q2 2022$92,000
-18.6%
104,258
+14.4%
0.00%
Q1 2022$113,000
-23.1%
91,139
+21.4%
0.00%
Q4 2021$147,000
-72.6%
75,101
-61.6%
0.00%
Q3 2021$536,000
-18.3%
195,335
-6.2%
0.00%
Q2 2021$656,000208,2370.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders